http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03016259-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ecec76402bdbc629251ca76f6402e55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f27e53d18bcd648e465738c097228c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b94d8c9a6afa959c1e097d5a3da3c2e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bdccc4a79b54fdea49f81c4aa33d5fe3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44664a6451821e1f1e528d12b1babda2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-612
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-67
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-612
filingDate 2002-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d338d36697120807401e7755d88a73d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_197fe9e06f0f3a62c04f4aaa107f8544
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c73eefa8d15286f290b76869a897435d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63b09537034cf7db145e6def58b953a4
publicationDate 2003-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-03016259-A2
titleOfInvention Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances
abstract The invention relates to compounds that contain lactic acid elements and that have the general formula (I), wherein is 1 to 16, and * means the chiral center of the lactic acid elements. The lactic acid elements are present on the chiral center either in a uniform or different configuration, optionally in the form of diastereomeric mixtures, wherein R1 represents either the acyl group of an active substance that is reactive under acidic conditions, and then X represents oxygen and R2 represents hydrogen or a straight-chain or branched alkyl group having 1 to 8 carbon atoms, or wherein R1 represents hydrogen, if X represents oxygen or NR', and R2 represents an active substance having a hydroxyl group (X represents oxygen) esterified with the lactic acid element or an active substance having an amine group (X represents NR') amidified with the lactic acid elements, wherein R' represents hydrogen for active substances of the primary amine type and for substances of the secondary amine type, and, if the secondary amine is not cyclic, represents the group on the amine group of the active substance, and, if the secondary amine is cyclic, represents the covalent bond of nitrogen to R2, in which case the general formula (I) defines a cyclic secondary amine. The compounds of general formula (I) can be produced from lactic acid oligomers or dimers in a simple manner. The invention further relates to drugs, especially prodrugs, that contain at least one compound of the general formula (I) together with a pharmaceutically acceptable excipient.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2810640-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102089117-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10125215-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014012805-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014195208-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2745065-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104470498-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104470498-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105392466-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150036091-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9315444-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008119518-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10934244-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1679301-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8425894-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11147788-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11730714-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9370502-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2674986-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8912232-B2
priorityDate 2001-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5883123-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-1020324-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5912269-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0573253-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5270331-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5401773-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5880152-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2116347-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9720812-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4216224-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID249182728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394091
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70038768
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7498
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245063445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226637077
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226501215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70036744
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167069
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70036745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128537742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393271
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72387276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232896288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232896471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226494310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399382
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232897292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70039273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127708637
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232892037
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232892039
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54051361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127633391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127402247

Total number of triples: 93.